Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Atsuya Karato"'
Autor:
Minori Yokoo, Asao Ogawa, Tomoko Takayama, Yuki Kikuuchi, Naoyuki Okamoto, Atsuya Karato, Tatsuo Akechi, Kayoko Katayama, Takako Nakanotani
Publikováno v:
Japanese journal of clinical oncology. 44(7)
Objective: Comprehensive assessment of perceived concerns can be used to guide supportive care appropriate to individual cancer patients. This study sought to determine the prevalence of cancer patients’ concerns and the degree to which these conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b384056fcfdf32a509a2992cc48430e
https://pubmed.ncbi.nlm.nih.gov/24829467
https://pubmed.ncbi.nlm.nih.gov/24829467
Autor:
Asao Ogawa, Takako Nakanotani, Minori Yokoo, Tomoko Takayama, Atsuya Karato, Tatsuo Akechi, Yuki Kikuuchi, Naoyuki Okamoto, Kayoko Katayama
Publikováno v:
Japanese journal of clinical oncology. 44(5)
Objective Cancer incidence and the number of cancer patients are increasing in today's aging society. The purpose of this study was to investigate the characteristics of elderly cancer patients' concerns and examine the association between their conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c27bfc78ad2620d08fe2914c3fd50cd
https://pubmed.ncbi.nlm.nih.gov/24706937
https://pubmed.ncbi.nlm.nih.gov/24706937
Autor:
Yuichi Ishikawa, Atsuya Karato, Shigehiro Tsuchiya, Makoto Nishio, Ken Nakagawa, Sakae Okumura
Publikováno v:
Haigan. 39:153-157
症例は50歳男性, 胸部X線写真にて左肺門部に異常陰影を指摘され, 当院受診.胸部X線写真及び胸部CTにて左B3b気管支内の腫瘍が疑われた.気管支鏡検査では, 左B3bを完全に閉塞する表面平滑
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a5fac655c9a37bc180eaa15fd635567
https://doi.org/10.2482/haigan.39.153
https://doi.org/10.2482/haigan.39.153
Autor:
Atsuya Karato, Hitoshi Arioka, Hajime Nakashima, Hiroshi Kunikane, Kenji Eguchi, Tomohide Tamura, Nagahiro Saijo, Yuichiro Ohe, Makoto Nishio, Yasutsuna Sasaki, Tetsu Shinkai, Hironobu Omatsu
Publikováno v:
Japanese Journal of Cancer Research : Gann
Paclitaxel, a new antitubular agent, appears to be one of the most promising single agents for the chemotherapy of various solid tumors. The primary objectives of this phase I study of paclitaxel using 24‐h continuous intravenous infusions were to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0342d88ce6150267903ae0f85a6f24
https://doi.org/10.1111/j.1349-7006.1994.tb02906.x
https://doi.org/10.1111/j.1349-7006.1994.tb02906.x
Publikováno v:
Japanese Journal of Cancer Research : Gann
Mitomycin C (MMC) at a dose of 8 mg/m2 was administered by short intravenous infusion to 14 cancer patients. All patients had normal renal, hepatic, cardiac and bone marrow functions. The plasma level of MMC, which was determined by high-performance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db3c67dfa595a1da534a77ae134e352
http://europepmc.org/articles/PMC5918739
http://europepmc.org/articles/PMC5918739
Autor:
Atsuya Karato, Yuichiro Ohe, Kenji Eguchi, Tomohide Tamura, Hiroaki Okamoto, Fumihiko Kanzawa, Nagahiro Saijo, Yasutsuna Sasaki, Hironobu Ohmatsu, Hiroshi Kunikane, Akira Kojima, Tetsu Shinkai
Publikováno v:
JNCI Journal of the National Cancer Institute. 84:972-974
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::519261062bcfac1702a1b5dcc7611792
https://doi.org/10.1093/jnci/84.12.972
https://doi.org/10.1093/jnci/84.12.972
Autor:
Hajime Nakashima, Ronald Lieberman, Atsuya Karato, Hitoshi Arioka, Hironobu Ohmatsu, Naohiro Nomura, Junichi Shiraishi, Tomohide Tamura, Kenji Eguchi, Tetsu Shinkai, Yasutsuna Sasaki, Nobuyuki Yamamoto, Minoru Hukuda, Fumihiro Oshita, Yuichiro Ohe, Nagahiro Saijo
Publikováno v:
Therapeutic drug monitoring. 17(3)
A linear two-compartment Bayesian pharmacokinetic model was developed using a standard two-stage population method for the novel anti-cancer agent CPT-11 from 11 adult patients with refractory cancer. The accuracy and efficiency of this Bayesian mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2c5d31d54e4033e9af4ad16e4e949b
https://pubmed.ncbi.nlm.nih.gov/7624917
https://pubmed.ncbi.nlm.nih.gov/7624917
Autor:
Tetsu Shinkai, Nagahiro Saijo, Hitoshi Arioka, Noriko Tada, Hironobu Ohmatsu, Hiroshi Kunikane, Masato Nisio, Tomohide Tamura, Yuichiro Ohe, Atsuya Karato, Kenji Eguchi, Yasutsuna Sasaki, Kinuko Tajima, Hajime Nakashima
Publikováno v:
Japanese Journal of Cancer Research : Gann
We carried out a randomized, single‐blind, cross‐over trial to compare the antiemetic effect, for both acute and delayed emesis, of granisetron plus dexamethasone (GRN+Dx) with that of high‐dose metoclopramide plus dexamethasone (HDMP + Dx). Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96bbfe6bfe1dd699b52f2d9d85bbd123
https://pubmed.ncbi.nlm.nih.gov/7829401
https://pubmed.ncbi.nlm.nih.gov/7829401
Autor:
Nobuyuki Yamamoto, Tomohide Tamura, Kazunori Uenaka, Yuichiro Ohe, Atsuya Karato, Jun-ichi Shiraishi, Minoru Fukuda, Shun Higuchi, Hitoshi Arioka, Kenji Eguchi, Hajime Nakashima, Fumihiro Oshita, Tetsu Shinkai, Nagahiro Saijo
Publikováno v:
Japanese Journal of Cancer Research : Gann
In this study, we aimed to develop a population pharmacokinetic model for CPT-11 and to use the Bayesian method to estimate CPT-11 pharmacokinetic parameters in each of 43 patients who received combined therapy consisting of CPT-11 and etoposide. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe7b8c8f33c4d5aef0561067e3864a6
https://pubmed.ncbi.nlm.nih.gov/7961128
https://pubmed.ncbi.nlm.nih.gov/7961128
Autor:
Kenji Eguchi, Hiroaki Okamoto, Atsuya Karato, Fumihiro Oshita, Yuichiro Ohe, Akira Kojima, Nagahiro Saijo, Yasutsuna Sasaki, Tetsu Shinkai, Tomohide Tamura, Hironobu Ohmatsu
Publikováno v:
Lung Cancer. 7:112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67cbd001624b4db1e2ea8d47f8b5e8ba
https://doi.org/10.1016/0169-5002(91)91764-3
https://doi.org/10.1016/0169-5002(91)91764-3